Oscar Health, Inc. $OSCR Shares Bought by Farallon Capital Management LLC

Farallon Capital Management LLC boosted its position in shares of Oscar Health, Inc. (NYSE:OSCR) by 146.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,639,000 shares of the company’s stock after buying an additional 2,163,000 shares during the period. Farallon Capital Management LLC owned 1.37% of Oscar Health worth $68,886,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the company. Farther Finance Advisors LLC boosted its stake in shares of Oscar Health by 4,420.7% in the third quarter. Farther Finance Advisors LLC now owns 1,311 shares of the company’s stock worth $25,000 after acquiring an additional 1,282 shares during the last quarter. Jones Financial Companies Lllp increased its position in shares of Oscar Health by 7,473.3% during the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after purchasing an additional 2,242 shares in the last quarter. Strs Ohio acquired a new position in Oscar Health in the 1st quarter valued at $30,000. Tsfg LLC acquired a new position in Oscar Health in the 3rd quarter valued at $38,000. Finally, EMC Capital Management purchased a new position in Oscar Health in the 2nd quarter valued at $64,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

Insider Transactions at Oscar Health

In related news, insider Mario Schlosser sold 23,038 shares of the firm’s stock in a transaction dated Thursday, January 8th. The shares were sold at an average price of $17.65, for a total transaction of $406,620.70. Following the completion of the sale, the insider directly owned 350,180 shares in the company, valued at approximately $6,180,677. This trade represents a 6.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders have sold 138,835 shares of company stock worth $2,298,269 in the last ninety days. 25.11% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

OSCR has been the topic of several recent research reports. Piper Sandler raised shares of Oscar Health from a “neutral” rating to an “overweight” rating and lifted their target price for the stock from $13.00 to $25.00 in a research note on Tuesday, November 25th. Wall Street Zen upgraded shares of Oscar Health from a “sell” rating to a “hold” rating in a research report on Saturday, February 14th. Raymond James Financial raised shares of Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 price target on the stock in a research note on Thursday, February 12th. Stephens started coverage on shares of Oscar Health in a research note on Thursday, December 11th. They set an “equal weight” rating and a $17.00 price objective for the company. Finally, Barclays set a $18.00 price objective on shares of Oscar Health and gave the company an “equal weight” rating in a research note on Monday, January 5th. Two analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $16.88.

Oscar Health Stock Performance

NYSE OSCR opened at $13.22 on Monday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.96 and a current ratio of 0.96. The stock’s fifty day moving average is $14.53 and its two-hundred day moving average is $16.47. The firm has a market capitalization of $3.93 billion, a P/E ratio of -7.59 and a beta of 1.90. Oscar Health, Inc. has a fifty-two week low of $11.20 and a fifty-two week high of $23.80.

Oscar Health (NYSE:OSCR) last issued its earnings results on Tuesday, February 10th. The company reported ($1.24) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.92) by ($0.32). Oscar Health had a negative return on equity of 39.35% and a negative net margin of 3.79%.The company had revenue of $2.81 billion during the quarter, compared to analyst estimates of $3.12 billion. During the same period last year, the business earned ($0.62) earnings per share. The firm’s revenue was up 17.3% compared to the same quarter last year. On average, research analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.